IS4774A - Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum - Google Patents
Lyfjafræðilegar samsetningar með D-vítamín hliðstæðumInfo
- Publication number
- IS4774A IS4774A IS4774A IS4774A IS4774A IS 4774 A IS4774 A IS 4774A IS 4774 A IS4774 A IS 4774A IS 4774 A IS4774 A IS 4774A IS 4774 A IS4774 A IS 4774A
- Authority
- IS
- Iceland
- Prior art keywords
- analogs
- vitamin
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19549243A DE19549243A1 (de) | 1995-12-21 | 1995-12-21 | Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga |
| PCT/EP1996/005856 WO1997023242A1 (de) | 1995-12-21 | 1996-12-20 | Pharmazeutische präparate mit vitamin d-analoga |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4774A true IS4774A (is) | 1998-06-15 |
Family
ID=7781710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4774A IS4774A (is) | 1995-12-21 | 1998-06-15 | Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0869819A1 (is) |
| JP (1) | JP2000502733A (is) |
| KR (1) | KR19990076637A (is) |
| CN (1) | CN1207687A (is) |
| AU (1) | AU1306997A (is) |
| CA (1) | CA2241205A1 (is) |
| DE (1) | DE19549243A1 (is) |
| HU (1) | HUP9903935A3 (is) |
| IL (1) | IL125020A0 (is) |
| IS (1) | IS4774A (is) |
| NO (1) | NO982874L (is) |
| WO (1) | WO1997023242A1 (is) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
| US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
| US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
| GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| DE102005017775A1 (de) * | 2005-04-13 | 2006-10-19 | Schering Ag | Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins |
| CA2882048C (en) | 2006-02-03 | 2020-03-24 | Proventiv Therapeutics, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| DK3357496T3 (da) | 2006-06-21 | 2020-05-11 | Opko Ireland Global Holdings Ltd | Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel |
| KR100822133B1 (ko) * | 2006-11-06 | 2008-04-15 | 한미약품 주식회사 | 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제 |
| US8592401B2 (en) | 2007-04-25 | 2013-11-26 | Proventiv Therapeutics, Llc | Methods and compounds for vitamin D therapy |
| EP2148683A4 (en) | 2007-04-25 | 2012-09-12 | Proventiv Therapeutics Llc | METHOD FOR THE SAFE AND EFFECTIVE TREATMENT AND PREVENTION OF SECONDARY HYPERPARATHYREOSIS IN CHRONIC KIDNEY DISEASE |
| KR101495578B1 (ko) | 2007-04-25 | 2015-02-25 | 사이토크로마 인코포레이티드 | 비타민 ｄ 부족 및 결핍의 치료 방법 |
| ES2956794T3 (es) | 2007-04-25 | 2023-12-28 | Eirgen Pharma Ltd | Liberación controlada de 25-hidroxivitamina D |
| EP2281058B1 (en) | 2008-04-02 | 2016-06-29 | Opko Ireland Global Holdings, Ltd. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
| EP3636280A1 (en) | 2010-03-29 | 2020-04-15 | Opko Ireland Global Holdings, Ltd. | Methods and compositions for reducing parathyroid levels |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| KR20180123100A (ko) | 2016-03-28 | 2018-11-14 | 옵코 아일랜드 글로벌 홀딩스 리미티드 | 비타민 d 치료 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177586B (en) * | 1978-12-19 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | New process for preparing stable inclusion complexes of vitamine d with cyclodextrin |
| JPS5910562A (ja) * | 1982-07-07 | 1984-01-20 | Teijin Ltd | プレ−１α−ヒドロキシコレカルシフエロ−ル類の製造法 |
| JPS5936656A (ja) * | 1982-08-23 | 1984-02-28 | Teijin Ltd | 新規包接化合物及びそれを活性成分とする薬剤 |
| JPS60120812A (ja) * | 1983-12-02 | 1985-06-28 | Teijin Ltd | 糖尿病性骨減少症治療剤 |
| DK0437225T3 (da) * | 1990-01-10 | 1994-06-27 | Hoffmann La Roche | Topiske præparater |
| IL107185A (en) * | 1992-10-06 | 1998-02-22 | Schering Ag | History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them |
-
1995
- 1995-12-21 DE DE19549243A patent/DE19549243A1/de not_active Withdrawn
-
1996
- 1996-12-20 KR KR1019980704745A patent/KR19990076637A/ko not_active Application Discontinuation
- 1996-12-20 HU HU9903935A patent/HUP9903935A3/hu unknown
- 1996-12-20 CA CA002241205A patent/CA2241205A1/en not_active Abandoned
- 1996-12-20 IL IL12502096A patent/IL125020A0/xx unknown
- 1996-12-20 WO PCT/EP1996/005856 patent/WO1997023242A1/de not_active Application Discontinuation
- 1996-12-20 EP EP96944669A patent/EP0869819A1/de not_active Withdrawn
- 1996-12-20 AU AU13069/97A patent/AU1306997A/en not_active Abandoned
- 1996-12-20 JP JP9523335A patent/JP2000502733A/ja active Pending
- 1996-12-20 CN CN96199734A patent/CN1207687A/zh active Pending
-
1998
- 1998-06-15 IS IS4774A patent/IS4774A/is unknown
- 1998-06-19 NO NO982874A patent/NO982874L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2241205A1 (en) | 1997-07-03 |
| NO982874L (no) | 1998-08-20 |
| KR19990076637A (ko) | 1999-10-15 |
| JP2000502733A (ja) | 2000-03-07 |
| HUP9903935A3 (en) | 2000-05-29 |
| EP0869819A1 (de) | 1998-10-14 |
| IL125020A0 (en) | 1999-01-26 |
| WO1997023242A1 (de) | 1997-07-03 |
| DE19549243A1 (de) | 1997-06-26 |
| NO982874D0 (no) | 1998-06-19 |
| CN1207687A (zh) | 1999-02-10 |
| HUP9903935A2 (hu) | 2000-03-28 |
| AU1306997A (en) | 1997-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9610153A (pt) | Formulações farmacêuticas | |
| BR9611626A (pt) | Formulações farmacéuticas | |
| DK0585252T3 (da) | Farmaceutiske formuleringer | |
| DK481989D0 (da) | Farmaceutiske formuleringer | |
| DE69615887D1 (de) | Oral anzuwendende Arzneizubereitung enthaltend Olanzapin | |
| NO962606L (no) | Farmasöytisk sammensetning | |
| NO961136D0 (no) | Farmasöytisk formuleringsgrunnlag for nano-suspensjoner | |
| NO981008D0 (no) | Farmasöytisk formulering | |
| IS4774A (is) | Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum | |
| PT808833E (pt) | Analogos da vitamina d3 | |
| BR9610214A (pt) | Compostos farmacéuticos | |
| ITMI921123A0 (it) | Formulazioni farmaceutiche orali contenenti antocianosidi | |
| DE69614407D1 (de) | Pharmazeutische zusammensetzungen | |
| ID16781A (id) | Formulasi-formulasi farmasi | |
| LV11727A (lv) | Farmaceitiska kompozicija | |
| TR199501082A2 (tr) | Farmasötik formülasyonlar. | |
| ITMI941169A0 (it) | Formulazioni farmaceutiche | |
| FI973280A (fi) | Farmaseuttinen koostumus | |
| FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
| NO965448D0 (no) | Farmasöytiske forbindelser | |
| DK0876367T3 (da) | Trans apovincaminsyreesterderivater som lægemidler | |
| BR9605777A (pt) | Composição farmacêutica | |
| NO964309D0 (no) | Farmasöytisk sammensetning | |
| SE9502453D0 (sv) | Drug formulations | |
| SE9404467D0 (sv) | Drug formulations |